Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HAPILA
Gera, Thuringia, Germanyhapila.de ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
HAPILA is a specialized Contract Development and Manufacturing Organization (CDMO) based in Germany that focuses on the development and production of active pharmaceutical ingredients (APIs). The company provides a comprehensive suite of services ranging from chemical process development and scale-up to GMP-compliant manufacturing for clinical trials and commercial supply. HAPILA is particularly recognized for its expertise in handling high-potency APIs (HPAPIs) and complex small molecules. Their service portfolio also includes analytical development, stability testing, and regulatory support to facilitate the transition of drug candidates from the laboratory to the market.
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on HAPILA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HAPILA.